- Home
- BOWL vs AMPH Comparison
BOWL vs AMPH Comparison
Compare BOWL & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOWL
- AMPH
- Stock Information
- Founded
- BOWL 1900
- AMPH 1996
- Country
- BOWL United States
- AMPH United States
- Employees
- BOWL N/A
- AMPH N/A
- Industry
- BOWL Services-Misc. Amusement & Recreation
- AMPH Biotechnology: Pharmaceutical Preparations
- Sector
- BOWL Consumer Discretionary
- AMPH Health Care
- Exchange
- BOWL Nasdaq
- AMPH Nasdaq
- Market Cap
- BOWL 1.6B
- AMPH 2.5B
- IPO Year
- BOWL N/A
- AMPH 2014
- Fundamental
- Price
- BOWL $10.82
- AMPH $51.45
- Analyst Decision
- BOWL Strong Buy
- AMPH Buy
- Analyst Count
- BOWL 9
- AMPH 4
- Target Price
- BOWL $16.00
- AMPH $63.00
- AVG Volume (30 Days)
- BOWL 366.9K
- AMPH 268.7K
- Earning Date
- BOWL 11-04-2024
- AMPH 11-06-2024
- Dividend Yield
- BOWL 1.91%
- AMPH N/A
- EPS Growth
- BOWL N/A
- AMPH 62.07
- EPS
- BOWL N/A
- AMPH 3.15
- Revenue
- BOWL $1,154,614,000.00
- AMPH $712,891,000.00
- Revenue This Year
- BOWL $9.73
- AMPH $18.04
- Revenue Next Year
- BOWL $7.42
- AMPH $4.41
- P/E Ratio
- BOWL N/A
- AMPH $16.26
- Revenue Growth
- BOWL 9.05
- AMPH 31.80
- 52 Week Low
- BOWL $8.85
- AMPH $36.56
- 52 Week High
- BOWL $15.47
- AMPH $65.92
- Technical
- Relative Strength Index (RSI)
- BOWL 42.52
- AMPH 59.40
- Support Level
- BOWL $11.15
- AMPH $49.38
- Resistance Level
- BOWL $11.79
- AMPH $51.84
- Average True Range (ATR)
- BOWL 0.43
- AMPH 1.25
- MACD
- BOWL -0.09
- AMPH 0.10
- Stochastic Oscillator
- BOWL 3.99
- AMPH 78.90
About BOWL Bowlero Corp.
Bowlero Corp is a operator of bowling entertainment centers. It operate traditional bowling centers and more upscale entertainment concepts with lounge seating, arcades, enhanced food and beverage offerings, and more robust customer service for individuals and group events, as well as hosting and overseeing professional and non-professional bowling tournaments and related broadcasting.
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.